Old Web
English
Sign In
Acemap
>
Paper
>
Serum GAL3 predict response in omalizumab-treated patients with severe allergic asthma: the PROXIMA study
Serum GAL3 predict response in omalizumab-treated patients with severe allergic asthma: the PROXIMA study
2018
Anna Maria Riccio
Pierluigi Mauri
Marta Bartezaghi
Fabiana Saccheri
Giorgio Walter Canonica
Keywords:
Physical therapy
Omalizumab
Asthma
Diabetes mellitus
Medicine
Internal medicine
allergic asthma
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]
map